Asia Clinical Trials and CRO Services for Medical Devices and Pharmaceuticals

Our experts can help you manage and expedite your clinical trials in Asia to get your products to market sooner.

clinical trials in asiaIf you need CRO assistance with clinical trials for your medical product in Asia, contact us now for a consultation with our Asia regulatory experts

When registering new medical products in Asia, there are various reasons Western companies may want or need to conduct local clinical trials. The most common reason is that the local Asian government may require the local clinical data for product registration. In addition, the large, genetically diverse population in Asia creates ideal sample populations, and the cost to perform clinical studies in Asia may be lower than in Western countries. In some cases, post market data may be required too.

An understanding of the regulatory requirements , an experienced, on the ground, local team providing contract research organization (CRO) services and experience in dealing with each Asian local regulatory authority is essential in administering a smooth, successful clinical trial in Asia. Pacific Bridge Medical (PBM) can act as your CRO or help you identify a qualified Asian CRO. Our on-the-ground clinical trial teams in Asia are highly experienced with the full clinical trial process and can ensure that it is conducted effectively and successfully.

We offer the following services for medical device, IVD, pharmaceutical, and biotechnology companies looking to conduct clinical trials in Asia:

  • Clinical Trial or CRO Consulting Services
    PBM will provide clinical trial consulting services, including consultations with each of the Asian governments. We can help you develop the best clinical trial strategy, clinical trial study design, and clinical trial protocol.
  • Regulatory Support
    We can submit clinical trial applications (CTA) and clinical trial notifications (CTN) as required for clinical trial initiation in each Asian country. Our on-the-ground teams consist of experienced Asian clinical trial professionals who will meet with the appropriate regulatory agencies on your behalf throughout the clinical study. We will provide guidance and help meeting the Institutional Review Board (IRB) and Independent Ethics Committee (IEC) requirements.
  • Clinical Trials Management
    We can comprehensively undertake and manage the clinical trials process by conducting the trials and completing the clinical trial reports. Our Asian CRO experts will evaluate clinical trial and non-clinical trial data; conduct gap analyses; and determine safety and efficacy requirements, along with primary and secondary endpoints, as required for your specific product.
  • Quality Compliance and Audits
    We can conduct your clinical trials and consult on various quality guidelines such as Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Good Pharmacovigilance Practices (GVP), Good Quality Practice (GQP), Good Manufacturing Practice (GMP), etc.
  • Adverse Events and Post Market Surveillance
    We will report adverse events during your clinical trial and implement suggestions on additional trials and required data. We can assist in post-approval and post-clearance clinical trials to maintain the safety, efficacy, and performance of the product through its life cycle.

Clinical trials that are conducted properly will facilitate a smooth registration approval process and expedite access to the Asian markets. If you need CRO assistance with clinical trials for your medical product in Asia, contact us now for a consultation with our Asia regulatory experts, or select your target market below for more information regarding clinical trials in each specific Asian country.

Select your target market

Related Resources

Visit our Resource Center to view free webcasts and charts or read publications, news, and research reports on the Asia medical markets.

Related News Briefs

Visit our Resource Center to view free webcasts and charts or read publications, news, and research reports on the Asia medical markets.